Dermatological oncology: advanced melanoma, side effects of anti-PD1, place of monotherapy in the first line, treatment of metastatic melanoma

被引：0
作者：
Kluger, N. [1 ,2 ]
Lebbe, C. [3 ]
Grange, F. [4 ]
Mortier, L. [5 ]
Robert, C. [6 ]
机构：
[1] CHU Helsinki, Serv Dermatol Allergol & Venereol, Helsinki, Finland
[2] Hop Peau & Allergies, Dept Dermatol, Meilahdentie 2,POB 160, Hjs 00029, Finland
[3] Hop St Louis, Serv Dermatol, Paris, France
[4] CHU Reims, Serv Dermatol, Reims, France
[5] CHU Lille, Serv Dermatol, Lille, France
[6] Inst Gustave Roussy, Serv Dermatol, Villejuif, France
来源：
ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE | 2017年 / 144卷
关键词：
BRAIN METASTASES; PEMBROLIZUMAB; IPILIMUMAB; TRIAL;
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：S11 / S14
页数：4
相关论文
共 5 条
  • [1] Melanoma Brain Metastasis Pseudoprogression after Pembrolizumab Treatment
    Cohen, Justine V.
    Alomari, Ahmed K.
    Vortmeyer, Alexander O.
    Jilaveanu, Lucia B.
    Goldberg, Sarah B.
    Mahajan, Amit
    Chiang, Veronica L.
    Kluger, Harriet M.
    [J]. CANCER IMMUNOLOGY RESEARCH, 2016, 4 (03) : 179 - 182
  • [2] Pembrolizumab for patients with melanoma or non-small-cell lung cancer and untreated brain metastases: early analysis of a non-randomised, open-label, phase 2 trial
    Goldberg, Sarah B.
    Gettinger, Scott N.
    Mahajan, Amit
    Chiang, Anne C.
    Herbst, Roy S.
    Sznol, Mario
    Tsiouris, Apostolos John
    Cohen, Justine
    Vortmeyer, Alexander
    Jilaveanu, Lucia
    Yu, James
    Hegde, Upendra
    Speaker, Stephanie
    Madura, Matthew
    Ralabate, Amanda
    Rivera, Angel
    Rowen, Elin
    Gerrish, Heather
    Yao, Xiaopan
    Chiang, Veronica
    Kluger, Harriet M.
    [J]. LANCET ONCOLOGY, 2016, 17 (07) : 976 - 983
  • [3] Stereotactic Radiosurgery for Melanoma Brain Metastases in Patients Receiving Ipilimumab: Safety Profile and Efficacy of Combined Treatment
    Kiess, Ana P.
    Wolchok, Jedd D.
    Barker, Christopher A.
    Postow, Michael A.
    Tabar, Viviane
    Huse, Jason T.
    Chan, Timothy A.
    Yamada, Yoshiya
    Beal, Kathryn
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 92 (02): : 368 - 375
  • [4] Pembrolizumab versus Ipilimumab in Advanced Melanoma
    Robert, Caroline
    Schachter, Jacob
    Long, Georgina V.
    Arance, Ana
    Grob, Jean Jacques
    Mortier, Laurent
    Daud, Adil
    Carlino, Matteo S.
    McNeil, Catriona
    Lotem, Michal
    Larkin, James
    Lorigan, Paul
    Neyns, Bart
    Blank, Christian U.
    Hamid, Omid
    Mateus, Christine
    Shapira-Frommer, Ronnie
    Kosh, Michele
    Zhou, Honghong
    Ibrahim, Nageatte
    Ebbinghaus, Scot
    Ribas, Antoni
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (26) : 2521 - 2532
  • [5] Anti-programmed-death-receptor-1 treatment with pembrolizumab in ipilimumab-refractory advanced melanoma: a randomised dose-comparison cohort of a phase 1 trial
    Robert, Caroline
    Ribas, Antoni
    Wolchok, Jedd D.
    Hodi, F. Stephen
    Hamid, Omid
    Kefford, Richard
    Weber, Jeffrey S.
    Joshua, Anthony M.
    Hwu, Wen-Jen
    Gangadhar, Tara C.
    Patnaik, Amita
    Dronca, Roxana
    Zarour, Hassane
    Joseph, Richard W.
    Boasberg, Peter
    Chmielowski, Bartosz
    Mateus, Christine
    Postow, Michael A.
    Gergich, Kevin
    Elassaiss-Schaap, Jeroen
    Li, Xiaoyun Nicole
    Iannone, Robert
    Ebbinghaus, Scot W.
    Kang, S. Peter
    Daud, Adil
    [J]. LANCET, 2014, 384 (9948) : 1109 - 1117
1